Management of enzyme de-induction in a woman with HIV on methadone maintenance switched from nevirapine- to bictegravir-based antiretroviral regimen.

The article offers information on the management of enzyme de-induction in a woman with HIV who was switched from a nevirapine- to bictegravir-based antiretroviral regimen. Topics include the challenges of methadone maintenance in HIV patients, drug interactions between antiretroviral medications and methadone, and the importance of monitoring and managing enzyme de-induction during antiretroviral regimen switches.